Endari

Sickle Cell Disease

Sickle cell disease (SCD) is a group of inherited red blood cell disorders that affects about 100,000 Americans. This disease is present in affected individuals at birth and causes the production of abnormal hemoglobin.1

Hemoglobin is a molecule in red blood cells that is responsible for delivering oxygen to organs throughout the body. Healthy red blood cells are round and flexible so they can move through even the smallest blood vessels. In someone with SCD, abnormal hemoglobin causes the red blood cells to become rigid and C-shaped, similar in appearance to a sickle.1

Sickled red blood cells die quickly, leading to a shortage of red blood cells, a condition named anemia. Also, sickled cells become stuck in the smaller blood vessels and block blood flow. The blockage of blood flow prevents tissues and organs from receiving the necessary oxygen.2

The signs and symptoms of SCD will vary from person to person because vessel blockage and insufficient oxygen transfer occurs throughout the body. Common symptoms of SCD include anemia, organ damage, ulcers, and pain crises. People with SCD are also at increased risk of life-threatening events such as acute chest syndrome.1

INDICATION

ENDARI [L-glutamine oral powder] is indicated to reduce the acute complications of sickle cell disease in adults and children 5 years and older.

IMPORTANT SAFETY INFORMATION

The most common side effects in clinical studies were constipation, nausea, headache, pain in the stomach area, cough, pain in the hands or feet, back pain, and chest pain.

Side effects that led to a stop in treatment during the clinical studies were 1 case each of overactive spleen (an organ that helps filter your blood), pain in the stomach area, indigestion, burning sensation and hot flash.

It is not known whether ENDARI is safe and effective in children younger than 5 years old with sickle cell disease.

Please see full Prescribing Information.

You are encouraged to report all possible negative side effects of ENDARI to Emmaus Medical, Inc. at 1-877-420-6493 or FDA at 1-800-FDA-1080 or www.fda.gov/medwatch.

  1. Hematology.org. (n.d.). Sickle Cell Disease. [online] Available at: https://www.hematology.org/Patients/Anemia/Sickle-Cell.aspx [Accessed 6 Sep. 2019].
  2. Centers for Disease Control and Prevention. (2017). What is Sickle Cell Disease? | CDC. [online] Available at: https://www.cdc.gov/ncbddd/sicklecell/facts.html [Accessed 10 Sep. 2019].